BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 19762537)

  • 1. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
    Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
    Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
    Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
    Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
    Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
    Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
    Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
    Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
    del Rio ML; Kaye J; Rodriguez-Barbosa JI
    Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
    Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG
    Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern.
    Kim YS; Ford RJ; Faber JA; Bell RH; Elenitoba-Johnson KS; Medeiros LJ
    Am J Clin Pathol; 2000 Jul; 114(1):41-6. PubMed ID: 10884798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.